Eighty-seven per cent of the studied isolates were resistant to imipenem. Genes 5 encoding metallo-β-lactamases or carbapenem-hydrolyzing oxacillinases were not 6 identified. The main mechanism associated with imipenem resistance was the loss 7 of outer membrane protein OprD. Identification of overexpressed ESACs and loss 8 of OprD was observed for 65% of the isolates, all being fully resistant to imipenem. 9
by Fey et al. (6) . Expression level results were standardized accordingly to the 89 transcription level of the constitutively expressed rpsL ribosomal gene (Table 3) 
(8). 90
Transcripts quantification was performed by using the QuantiFast TM SYBR ® Green RT-91 PCR kit on a LightCycler 1.0 instrument (Roche Diagnostics, Neuilly-sur-Seine, 92
France). Isolates were considered to be MexAB-OprM, MexXY-OprM or MexCD-OprJ 93 hyperproducers when the level of expression of mexB, mexY and mexD was at least two, 94 four or two-fold higher than that of PAO1, respectively, according to previously defined 95 9 of OprD was the result of a disruption of the coding sequence by a novel 1.3-kb IS 118 element, named ISPa27 (submitted to the IS database at the internet site http://www-119 is.biotoul.fr/), in six clonally-related isolates (clone E2). 120
We also identified a shortened putative loop L7 of the OprD porin in the clones 121 B2, O and W, respectively (Table 4) . That shortening may open the porin channel to 122 allow optimal penetration of meropenem and increase its activity (5). Conversely, this 123 alteration might not modify the susceptibility to a smaller-sized carbapenem molecule, 124 such as imipenem (5). Interestingly, downregulated expression of the oprD gene 125 observed in these clones may modulate the phenotype of imipenem and meropenem 126 resistance (Table 2) . 127 β-Lactamase expression. Synergy tests performed with clavulanic acid-128 ticarcillin and ceftazidime containing disks did not evidence any inhibition of 129 ceftazidime resistance for all the P. aeruginosa isolates, ruling out the production of 130 extended spectrum β-lactamases (ESBLs). Using cloxacillin-containing plates, the 131
MICs of ceftazidime were decreased by at least two-folds for 25 out of 32 isolates (78% 132 of total), suggesting overproduction of the AmpC that was confirmed by determination 133 on July 7, 2017 by guest http://aac.asm.org/ Downloaded from variants, eight of those variants possessing an alanine residue at position 105 (Table 2) . 138
This residue had been previously shown to be the key factor for an ESAC property 139 ( Noteworthy, the prevalence of ESAC encoding genes in our collection was very 164 high, 28 out of the 32 isolates. In addition, overproduction of those ESAC enzymes was 165 evidenced in most of the isolates (75%). Basically, when considering the high rate of 166
OprD deficient isolates, it might be hypothetized that ESAC overproduction could play 167 a secondary but additive role toward reduced susceptibility or resistance to imipenem. 168
Of note, the additive presence of overexpressed ESACs and loss of OprD was correlated 169 with resistance to imipenem in all cases (Tables 1 and 2) . 170
On the other hand, the main mechanism associated to reduced susceptibility or 171 resistance to meropenem was probably overexpression of efflux pumps identified in 172 60% of the isolates together with the loss of OprD. ESAC overexpression (65% of the 173 isolates) could play an additive role in reduced susceptibility or resistance to 174 meropenem. Thirteen isolates did not overexpress any efflux pump, suggesting that the 175 lack of OprD, AmpC overexpression, ESAC β-lactamase production (or other unknown 176 mechanisms) may explain meropenem resistance (9). The additive presence of 177 overexpressed ESACs and overexpression of at least one efflux pump correlated with 178 resistance to meropenem in 87.5% of the cases (14 out of 16 isolates with this 179 combination of mechanisms of resistance) (Tables 1 and 2) . 
